Continuing Professional Developement (CPD): Cardiovascular disease and HIV

The first of a series of four articles providing an opportunity to earn CPD points. Among the many comorbidity conditions, cardiovascular disease (CVD) has become an area of particular concern in the field of HIV. The high prevalence of cardiovascular risk factors in people living with HIV, alongside the growing evidence of HIV-accelerated inflammatory processes, known to promote atherosclerosis, presents an ongoing challenge. This article has been prepared to aid your continuing professional development and with revalidation in mind.

HIV Nursing 2017; 17: 3–15.

Juliet Bennett
Independent Nurse Advisor

Understanding factors behind the late testing and diagnoses of HIV: a review of the international literature

Late diagnosis of HIV results in increased morbidity and mortality and raises the potential for onward transmission to others. It also increases costs to health-service providers and impacts on national health budgets. This is a review of the literature available from an international study investigating barriers to early HIV testing from the perspectives of both patients and healthcare professionals.

Stephen J. O'Connor & Sharon Manship
Canterbury Christ Church University & Canterbury Christ Church University

Innovation in HIV nursing: the Liverpool Community Clinic

The Liverpool Community Clinic (LCC) was established to address the pressing problem of non-attendance to hospital by people who are living with HIV (PLWH). This group now receives timely, safe and appropriate care while being managed remotely. The aims of the LCC are to reduce hospital admissions, manage side effects, guarantee medication and adherence, identify psychosocial factors that impact on engagement and retention in care, and enable person-centred care incorporating shared decision making.

HIV Nursing 2017; 17: 16–19.

Pauline Jelliman
Operational and Clinical lead for TB and HIV

HIV among people using anabolic steroids in the United Kingdom: an overview

Since the mid-1980s, preventing HIV transmission among people who inject drugs (PWIDs) has been one of the cornerstones of the UK’s response to HIV. The early comprehensive implementation of harm reduction, particularly needle and syringe programmes, has been widely acknowledged as key to a low prevalence of HIV among PWIDs in the UK. However, this harm-reduction strategy was developed to avert an HIV epidemic among people injecting heroin and while the prevalence in this population remains low, it is clear that there are now emerging populations of PWIDs with different patterns of drug use and risks.

HIV Nursing 2017; 17: 20–23.

Geoff Bates, Vivian Hope, Jim McVeigh
Researcher, Public Health Institute,Public Health Institute,Public Health Institute

Pop it up! The suitability and acceptability of community-based pop-up sexual health screening for men who have sex with men

Bournemouth has one of the highest rates of HIV in the UK, a diverse community associated with high rates of partner change and complex, hard-to-reach sexual networks. However, an emphasis has now been placed on the availability of community-based screening programmes in order to increase testing coverage [3] particularly among identified most at-risk populations (MARPs).

HIV Nursing 2017; 17: 27–30.

Kevin Turner
Sexual health advisor

Examining the impact on HIV and hepatitis C co-infection in the era of ‘ChemSex’

This article examines the rising incidence of HIV and hepatitis C infections amongst MSM (men who have sex with men) patients, and how the use of recreational drugs in the ‘era of ChemSex’ is contributing to the rise of co-infection.

Joe Philiips
Nurse Practitioner, 56 Dean Street

HIV Nursing

Sharing best practice in HIV care

Published by Mediscript Ltd


  • Mediscript Ltd 1 Mountview Court. 310 Friern Barnet Lane. London , N20 OLD.


Company Information

Registration name: Mediscript Ltd
Place of registration: Whetstone London, UK
Company registration No. : 2128686
Tel: 0208 446 8898
Contact Name : Ms Fatima Patel

Currently,​ we can accept payments in the following currencies through our website: